(Q24187358)

title

Antidepressants for the treatment of depression in people with cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

Faith Matcham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

Matthew Hotopf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

author name string

Sarah Dauchy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

Corrado Barbui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

1 June 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

page(s)

CD011006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

Fluoxetine Versus Placebo in Advanced Cancer Outpatients: A Double-Blinded Trial of the Hoosier Oncology Group

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Slow versus standard up-titration of paroxetine for the treatment of depression in cancer patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The role of paroxetine in fatigue and depression of patients under chemotherapeutic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Bupropion for control of hot flashes in breast cancer survivors: a prospective, double-blind, randomized, crossover, pilot phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Combined therapy versus usual care for the treatment of depression in oncologic patients: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Psychotherapy for depression among incurable cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Breast cancer and antidepressant use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depressed patients with incurable cancer: which depressive symptoms do they experience?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Single data extraction generated more errors than double data extraction in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Adjustment disorders: the state of the art

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Out of sight but not out of mind: how to search for unpublished clinical trial evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Imputing missing standard deviations in meta-analyses can provide accurate results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Relative mortality from overdose of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Novel melatonin-based therapies: potential advances in the treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Interpretation of tests of heterogeneity and bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depression and insomnia in cancer: prevalence, risk factors, and effects on cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Relationship of depression to medical illness. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Quality of life of family caregivers at 2 years after a relative's cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Novel glutamatergic drugs for the treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Evidence-based treatment of depression in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants for depressed elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The prevalence and pharmacotherapy of depression in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

A consumer's guide to subgroup analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depression and cancer mortality: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depression in cancer: new developments regarding diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants for depression in physically ill people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The development of evidence-based European guidelines on the management of depression in palliative cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Reevaluating the role of antidepressants in cancer-related depression: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The treatment of depression in cancer patients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Pharmacological treatment of depression in patients with a primary brain tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Pharmacological treatment of depression in patients with a primary brain tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The molecular neurobiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Suicidality and its associated factors in cancer patients: results of a multi-center study in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Drugs versus placebo for dysthymia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Treatment of depression in adults with cancer: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Antidepressants for the treatment of depression in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

Depression and degree of acceptance of adjuvant cytotoxic drugs

21 January 2018

1 reference

12 December 2020

DEPRESSION AMONG MEDICALLY ILL PATIENTS

1 reference

12 December 2020

Improving adherence to antidepressants: a systematic review of interventions

1 reference

12 December 2020

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

1 reference

12 December 2020

Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study

1 reference

12 December 2020

Depression--an independent predictor of early death in patients with advanced cancer

1 reference

12 December 2020

A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain

1 reference

12 December 2020

Drugs versus placebo for dysthymia

1 reference

12 December 2020

Treatment of depression in cancer patients is associated with better life adaptation: a pilot study

1 reference

12 December 2020

Efficacy and safety of mianserin in the treatment of depression of women with cancer.

1 reference

12 December 2020

The effect of fluoxetine on anxiety and depression symptoms in cancer patients

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Abstracts of the IPOS 11th World Congress of Psycho-Oncology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

7 January 2021

inferred from DOI database lookup

Abstracts of the IPOS 12th World Congress of Psycho-Oncology. May 25-29, 2010. Quebec City, QC, Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD011006.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD011006.PUB2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6457578&resulttype=core&format=json

13 May 2020

1 reference